tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market

Halozyme (HALO) Technical Analysis

Compare
1,020 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is -0.64, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 53.54, while Halozyme Therapeutics’s (HALO) share price is $54, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 55.15, while Halozyme Therapeutics’s (HALO) share price is $54, making it a Sell.

Halozyme (HALO) Pivot Points

Jul 07, 2025, 02:06 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
51.43
52.07
52.96
53.60
54.49
55.13
56.02
Fibonacci
52.07
52.66
53.02
53.60
54.19
54.55
55.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Jul 07, 2025, 02:06 PM
Period
Simple
Exponential
MA5
53.00Buy
53.34Buy
MA10
52.94Buy
53.20Buy
MA20
53.39Buy
53.54Buy
MA50
55.82Sell
55.15Sell
MA100
58.08Sell
56.15Sell
MA200
55.52Sell
55.72Sell
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 53.20, while Halozyme Therapeutics’s (HALO) share price is $54, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 56.15, while Halozyme Therapeutics’s (HALO) share price is $54, making it a Sell.
Halozyme Therapeutics’s (HALO) stock price is $54 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 55.82, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $54 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 58.08, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $54 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 55.52, creating a Sell signal.

Halozyme (HALO) Technical Indicators

Jul 07, 2025, 02:06 PM
Name
Value
Implied Action
RSI (14)
50.36
Neutral
STOCH (9,6)
79.97
Neutral
STOCHRSI (14)
68.53
Neutral
MACD (12,26)
-0.64
Sell
ADX (14)
15.12
Buy
Williams %R
-15.03
Sell
CCI (14)
44.38
Neutral
ATR (14)
1.56
-
Ultimate Oscillator
48.02
Neutral
ROC
-0.99
Sell
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 50.36, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 15.12, creating a Buy signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 44.38, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is -0.99, creating a Sell signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Hold.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 50.36, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is -0.64, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 53.00, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 53.39, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 55.82, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 55.52, which suggests HALO is a Sell.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -15.03, which suggests HALO is a Sell.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 44.38, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis